Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05286931
NA
SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection
Sponsor: University of Washington
View on ClinicalTrials.gov
Summary
This study aims to test the effectiveness of using of SpeeDx Resistance Plus assay to guide treatment of Neisseria gonorrhoeae (Ng) in a sexual health clinic setting.
Official title: Evaluation of SpeeDx's Ciprofloxacin gyrA Assay for Clinical Care of STD Clinic Patients With Neisseria Gonorrhea
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1800
Start Date
2022-03-03
Completion Date
2026-12-31
Last Updated
2022-03-18
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Ciprofloxacin 500 mg
Ciprofloxacin 500 MG, taken once orally.
Locations (1)
Public Health -- Seattle & King County Sexual Health Clinic
Seattle, Washington, United States